Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Methofill 20mg/0.4ml inj pre-filled injector
1001030U0BGAFBW
|
Methofill (Rheumatism) | Methotrexate | Musculoskeletal and Joint Diseases | 823 |
|
Methofill 15mg/0.3ml inj pre-filled injector
1001030U0BGADCC
|
Methofill (Rheumatism) | Methotrexate | Musculoskeletal and Joint Diseases | 531 |
|
Methofill 25mg/0.5ml inj pre-filled injector
1001030U0BGAHCB
|
Methofill (Rheumatism) | Methotrexate | Musculoskeletal and Joint Diseases | 460 |
|
Methofill10mg/0.2ml inj pre-filled injector
1001030U0BGABCE
|
Methofill (Rheumatism) | Methotrexate | Musculoskeletal and Joint Diseases | 242 |
|
Methofill 20mg/0.4ml inj pre-filled syringes
1001030U0BGAPBH
|
Methofill (Rheumatism) | Methotrexate | Musculoskeletal and Joint Diseases | 152 |
|
Methofill 25mg/0.5ml inj pre-filled syringes
1001030U0BGARBI
|
Methofill (Rheumatism) | Methotrexate | Musculoskeletal and Joint Diseases | 99 |
|
Methofill 12.5mg/0.25ml inj pre-filled injector
1001030U0BGACCD
|
Methofill (Rheumatism) | Methotrexate | Musculoskeletal and Joint Diseases | 98 |
|
Methofill 17.5mg/0.35ml inj pre-filled injector
1001030U0BGAEBV
|
Methofill (Rheumatism) | Methotrexate | Musculoskeletal and Joint Diseases | 91 |
|
Methofill 15mg/0.3ml inj pre-filled syringes
1001030U0BGAMBG
|
Methofill (Rheumatism) | Methotrexate | Musculoskeletal and Joint Diseases | 89 |
|
Methofill 10mg/0.2ml inj pre-filled syringes
1001030U0BGALBF
|
Methofill (Rheumatism) | Methotrexate | Musculoskeletal and Joint Diseases | 72 |
|
Methofill 22.5mg/0.45ml inj pre-filled injector
1001030U0BGAGBX
|
Methofill (Rheumatism) | Methotrexate | Musculoskeletal and Joint Diseases | 66 |
|
Methofill 7.5mg/0.15ml inj pre-filled injector
1001030U0BGAABY
|
Methofill (Rheumatism) | Methotrexate | Musculoskeletal and Joint Diseases | 51 |
|
Methofill 17.5mg/0.35ml inj pre-filled syringes
1001030U0BGANBL
|
Methofill (Rheumatism) | Methotrexate | Musculoskeletal and Joint Diseases | 26 |
|
Methofill 12.5mg/0.25ml inj pre-filled syringes
1001030U0BGAUBK
|
Methofill (Rheumatism) | Methotrexate | Musculoskeletal and Joint Diseases | 19 |
|
Methofill 22.5mg/0.45ml inj pre-filled syringes
1001030U0BGAQBM
|
Methofill (Rheumatism) | Methotrexate | Musculoskeletal and Joint Diseases | 14 |
|
Methofill 7.5mg/0.15ml inj pre-filled syringes
1001030U0BGAKBE
|
Methofill (Rheumatism) | Methotrexate | Musculoskeletal and Joint Diseases | 4 |
|
Methofill 30mg/0.6ml inj pre-filled injector
1001030U0BGAJCA
|
Methofill (Rheumatism) | Methotrexate | Musculoskeletal and Joint Diseases | 2 |
|
Methofill 30mg/0.6ml inj pre-filled syringes
1001030U0BGATBJ
|
Methofill (Rheumatism) | Methotrexate | Musculoskeletal and Joint Diseases | 2 |
|
Methofill 27.5mg/0.55ml inj pre-filled injector
1001030U0BGAIBZ
|
Methofill (Rheumatism) | Methotrexate | Musculoskeletal and Joint Diseases | No data available |
|
Methofill 27.5mg/0.55ml inj pre-filled syringes
1001030U0BGASBN
|
Methofill (Rheumatism) | Methotrexate | Musculoskeletal and Joint Diseases | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.